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Background: Infective endocarditis (IE) is still associated with high mortality and morbidity despite 
advances in diagnostic, medical and surgical management. 
 
Aims: I. To report short- and mid-term results after surgical treatment of IE in the current era and to 
compare the results between native valve endocarditis (NVE) and prosthetic valve endocarditis (PVE). 
II. To prospectively compare the ability of electrocardiogram (ECG)-gated computer tomography (CT) 
and transoesophageal echocardiography (TEE) to diagnose aortic PVE. III. To report our experience 
with implantation of aortic homografts in patients with aortic PVE or NVE with abscess. IV. To report 
the outcome of all patients operated for aortic PVE at our institution over the past 20 years and to 
examine whether the results have improved over time. 
 
Methods and methods: In Study I, outcome after all consecutive patients operated for IE from 2008 
to 2015 (n=254) was analysed. In Study II, 27 consecutive patients with aortic PVE underwent 64-
sliced ECG-gated CT and TEE, and the results were compared and related to surgical findings. In 
Study III, outcome and Quality of life (QoL) in patients (n=62) with aortic PVE or NVE with abscess 
operated with implantation of an aortic homograft were analysed. In Study IV, outcome after all 
consecutive patients operated (n=87) for aortic PVE from 1993 to 2013 was analysed. 
 
Results: In Study I, overall 30-day mortality was 8.7% and there was no statistically significant 
difference in 30-day mortality between patients with NVE and PVE (7.7% vs 11.1%, p=0.31). Thirty-
nine percent of the patients had severe perioperative complications. Overall survival at one and five 
years was 86% and 75%, respectively. In Study II, agreement was good between surgical findings and 
imaging with ECG-gated CT and TEE and very good for the combination of CT and TEE. ECG-gated 
CT identified more abscesses and thickened aortic root wall while TEE detected more valvular 
dehiscence and vegetations. In Study III, overall 30-day mortality was 15%. Thirty-five percent of the 
patients had severe perioperative complications. Cumulative survival was 82%, 78%, 75%, and 67% 
at one, three, five and ten years, respectively. QoL did not differ significantly between the homograft 
patients and an age- and gender-matched normal control group. In Study IV, overall 30-day mortality 
was 10%. Forty-one percent of the patients had severe perioperative complications. Cumulative 
survival was 81% at five years and 75% at ten years. Thirty-day mortality was higher (22% vs 3.6%, 
p=0.007) and five-year cumulative survival was lower (66% vs. 88% p=0.013) during the first decade. 
 
Conclusions: Surgery for infective endocarditis was associated with high early mortality and a 
considerable complication rate. Long-term outcome was acceptable. Morbidity and mortality were 
comparable in NVE and PVE patients. ECG-gated CT had comparable diagnostic performance to TEE 
in patients with aortic PVE and may be a complement to TEE. Acute aortic PVE and NVE with 
abscess formation treated with aortic homograft had substantial early complication rate and mortality. 
Long-term survival and QoL were satisfactory in patients surviving the immediate postoperative period. 
Aortic PVE was associated with a high rate of early complications and substantial early mortality. 
Long-term survival was satisfactory. The results have improved markedly during the past decade. 
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